2024-516472-15-00CompletedPhase 1
A phase 1 glucose clamp trial investigating the bioequivalence of CVC-001 cartridge vs U.S.-Licensed Lantus® in healthy male volunteers
Source: EU CTIS (euclinicaltrials.eu) · Last updated 6 May 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 76 (actual)
- First submitted
- 15 Oct 2025
- Start date
- 6 Jan 2026
- Lead sponsor
- Civica Inc.
- EU CT number
- 2024-516472-15-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 76
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| PROFIL Institut fuer Stoffwechselforschung GmbH | Neuss | Germany | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.